Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

October 22, 2002; 59 (8) Brief Communications

Stroke in ovarian hyperstimulation syndrome in early pregnancy treated with intra-arterial rt-PA

K. Elford, A. Leader, R. Wee, P.K. Stys
First published October 22, 2002, DOI: https://doi.org/10.1212/01.WNL.0000032492.77156.35
K. Elford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Leader
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Wee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.K. Stys
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Stroke in ovarian hyperstimulation syndrome in early pregnancy treated with intra-arterial rt-PA
K. Elford, A. Leader, R. Wee, P.K. Stys
Neurology Oct 2002, 59 (8) 1270-1272; DOI: 10.1212/01.WNL.0000032492.77156.35

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
387

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Ovarian hyperstimulation syndrome (OHSS) caused by fertility medications can predispose women to thrombosis. The authors present a case of a previously healthy woman who underwent in vitro fertilization and experienced a middle cerebral artery thrombosis that was subsequently lysed with intra-arterial recombinant tissue plasminogen activator (rt-PA). To the authors’ knowledge, this is the first reported case of successful use of rt-PA to lyse a cerebral arterial thrombus resulting from severe OHSS. The patient made a near complete neurologic recovery and delivered a healthy infant at term, illustrating that intra-arterial thrombolysis can be used with relative safety even in very early pregnancy.

Ovarian hyperstimulation syndrome (OHSS) is the most serious complication of fertility medications, requiring hospitalization in up to 2% of cases.1 In its severest form, OHSS can result in thromboembolism, adult respiratory distress syndrome, pleural effusions, significant ascites, renal insufficiency, liver dysfunction, and even death. Thromboembolic disease associated with the use of the reproductive technologies is considered extremely rare, with most reported cases involving venous thrombosis.2 Stroke is a rare (14 cases reported) and potentially fatal complication of controlled ovarian hyperstimulation, and timely intervention is critical.

Case report.

The patient is a nonsmoking 28-year-old nulligravida with 7 years of primary infertility and four unsuccessful cycles of ovulation induction. In vitro fertilization was undertaken for male factor infertility using an oral contraceptive–gonadotropin-releasing hormone agonist–recombinant follicular stimulating hormone (rec-FSH) long protocol starting with 200 IU rec-FSH daily. Despite close observation she over-responded to the gonadotropins, and her estradiol peaked at 11,500 pmol/L. She was coasted (no medication given) for 3 days prior to her human chorionic gonadotropin (HCG) injection (to mature her oocytes) on day 14 when her estradiol was 10,460 pmol/L. Sixteen mature eggs were retrieved from her ovaries and injected with her husband’s sperm. Two excellent quality day 3 embryos were transferred back into the patient, and eight of good quality were cryopreserved for future use. Four days after embryo transfer she had abdominal bloating and enlarged ovaries on examination, with normal complete blood count (CBC), electrolyte, and albumin determinations. She was assessed as needed in the fertility clinic and presented at 7 days after embryo transfer with dehydration, dyspnea, and nausea. She was immediately admitted to the hospital with severe OHSS and a large right pleural effusion. She was treated with IV fluids, albumin, and prophylactic subcutaneous heparin. Her initial CBC, after a 1-liter bolus of IV saline showed a white blood cell count (WBC) of 21.5 109/L (normal 3 to 10), hemoglobin 165 g/L (normal 115 to 155), hematocrit 0.50 L/L (normal 0.35 to 0.45), and platelet count 423 109/L (normal 125 to 400). Seven hours after admission and IV rehydration, she developed sudden left hemiplegia, dysarthria, left facial paralysis, and drowsiness (National Institute of Health Stroke Scale score of 11). Her blood pressure was 100 to 115/50 to 65 mm Hg throughout. An emergency CT scan confirmed subtle ischemic changes in the right middle cerebral artery (MCA) distribution including the perisylvian, frontal, and parietal opercular regions as well as the posterior aspect of the right basal ganglia (figure 1A). Angiography at 4 hours after stroke onset revealed complete occlusion of the right M1 segment of the MCA (figure 2A). Selective intermittent injection of a total of 15.5 mg of intra-arterial rt-PA via microcatheter over 68 minutes resulted in recanalization of the main trunk and anterior branch of the MCA (figure 2B), with marked concomitant improvement in neurologic status (NIHSS score 3). A postlysis CT showed a small 1.5- × 2.0-cm hematoma in the right basal ganglia (figure 1B). Three hours later she suffered worsening hemiparesis and hemisensory loss, with a repeat CT showing enlargement of the hematoma to 3.0 cm. General treatment included IV fluids and bilateral pigtail catheter drainage of her pleural effusions. Her hyperstimulation resolved slowly over 3 weeks, as she was pregnant with a singleton. There was no evidence of thrombophilia on extensive testing, and there were no structural cardiac anomalies. Her neurologic status improved gradually, and by 3 months she had only a mild incomplete left inferior quadrantanopia, normal strength, slight subjective sensory alteration in the left leg, and mild circumduction when ambulating. She was maintained on low-dose dalteparin for stroke prophylaxis until the last 2 months of her pregnancy. She delivered a healthy male infant at term by spontaneous vaginal delivery.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. (A) Axial noncontrast CT obtained before thrombolysis showed effacement of sulci in the right hemisphere in the perisylvian area and extending toward the convexity to involve the frontal and parietal opercular regions. The insular ribbon was preserved, but subtle hypodensity was seen in the right basal ganglia on other cuts. (B) Repeat CT obtained shortly after completion of intra-arterial thrombolysis with 15.5 mg of rt-PA showed a 1.5- × 2.0-cm hematoma in the posterior aspect of the right basal ganglia. The patient had virtually no neurologic deficits at this point.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. (A) Prelysis arteriogram (anteroposterior view) showed complete occlusion of the M1 segment of the right middle cerebral artery (arrow). (B) Repeat injection after selective administration of 15.5 mg of rt-PA demonstrates recanalization of the anterior branch of the MCA (arrowheads), but the posterior branch remained occluded. Because of marked neurologic improvement, the procedure was terminated at this point and the patient sent for repeat CT (figure 1B).

Discussion.

Close monitoring of follicular development and serum estradiol levels is mandatory in patients at high risk for the development of severe OHSS. In patients at extremely high risk, some clinics delay HCG administration, which can prevent OHSS and its attendant complications. We found 14 published case reports (1960 to present) of stroke in patients suffering from OHSS: six patients recovered with minimal or no sequelae, six were left with hemiparesis, and two died.3-6⇓⇓⇓ The MCA was occluded in six cases. While six cases were treated with IV heparin, there are no reports where intra-arterial thrombolysis was administered. Because most of these cases reported large arterial branch occlusions, which are associated with a relatively poor outcome,7 and given that anticoagulation alone offers little benefit in the acute phase,8 a more aggressive approach in these patients may be indicated.

Overall a net benefit of IV and intra-arterial thrombolysis has been demonstrated in acute ischemic stroke.9 Given the time elapsed after symptom onset and fairly widespread subtle ischemic changes on the initial CT, we elected to proceed with intra-arterial lysis in our case. The initial dramatic recovery paralleled partial reopening of the M1 occlusion. Approximately 10% of patients so treated will deteriorate due to intracerebral hemorrhage, but despite these complications, a significantly improved clinical outcome was observed. Our patient may have been at higher risk of hemorrhage because of early CT changes and a relatively proximal MCA occlusion that involved fragile lenticulostriates. Although there is significant debate in the field of acute stroke intervention, there nevertheless appears to be general agreement that intra-arterial thrombolysis is a reasonable treatment option for selected patients.10 Our case suggests that in addition to standard treatment of severe OHSS (IV fluids, electrolyte and serum protein monitoring, thoraco-paracentesis, and prophylactic heparin), treatment of acute ischemic stroke can be done relatively safely and effectively with intra-arterial thrombolysis using rt-PA. The rapid onset of severe dehydration and prothrombotic tendency highlight the need for close monitoring and rapid intervention in women with symptomatic OHSS.

  • Received February 18, 2002.
  • Accepted July 3, 2002.

References

  1. ↵
    Smitz J, Camus M, Devroey P, et al. Incidence of severe ovarian hyperstimulation syndrome after GnRH/HMG superovulation for IVF. Hum Reprod . 1990; 5: 933–937.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Alboulghar M, Mansour R, Serour G, Amin Y. Moderate ovarian hyperstimulation syndrome complicated by deep cerebrovascular thrombosis. Hum Reprod . 1998; 13: 2088–2091.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Sadek M, Amer M, Fahmy M. Acute cerebrovascular accidents with severe ovarian hyperstimulation syndrome. Hum Reprod . 1998; 13: 1793–1795.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Murrle G, Wetzel V, Burck C, et al. Floating thrombus of the internal carotid artery as a rare complication in ovarian hyperstimulation syndrome after in vitro fertilization/embryo transfer [in German]. Chirurg . 1998; 69: 1105–1108.
    OpenUrlPubMed
  5. ↵
    Hwang W, Ming-Liang L, Chao-Chin H, et al. Ischemic stroke in a young woman with ovarian hyperstimulation syndrome. J Formos Med Assoc . 1998; 97: 503–506.
    OpenUrlPubMed
  6. ↵
    Cluroe A, Synek B. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology . 1995; 27: 334–336.
    OpenUrl
  7. ↵
    Demchuk A, Buchan A. Predictors of stroke outcome. Neurol Clin . 2000; 18: 455–473.
    OpenUrlPubMed
  8. ↵
    Gubitz G, Counsell C, Sandercock P, Signorini D. Anticoagulants for acute ischaemic stroke. 2000 Cochrane Database Syst Rev 2:CD000024.
  9. ↵
    Wardlaw J. Overview of Cochrane thrombolysis meta-analysis. Neurology . 2001; 57: S69–S76.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Executive Committee of the ASITN. American Society of Interventional and Therapeutic Neuroradiol. Intraarterial thrombolysis: ready for prime time? AJNR Am J Neuroradiol . 2001; 22: 55–58.
    OpenUrlFREE Full Text

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Case report.
    • Discussion.
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis

Dr. Robert Pitceathly and Dr. William Macken

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Cerebrovascular disease/Stroke
  • Medical care

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Training, Certification, & Practice Standards
    Developing practice recommendations for endovascular revascularization for acute ischemic stroke
    Marc A. Lazzaro, Roberta L. Novakovic, Andrei V. Alexandrov et al.
    Neurology, September 24, 2012
  • Resident and Fellow Section
    Clinical Reasoning: An unusual case of blurry vision in a young woman after ovarian induction
    Neal S. Parikh, Darya Khazanova, Antonio Moya et al.
    Neurology, August 01, 2016
  • Article
    Effect of endovascular reperfusion in relation to site of arterial occlusion
    Robin Lemmens, Scott A. Hamilton, David S. Liebeskind et al.
    Neurology, January 22, 2016
  • Clinical/Scientific Notes
    Ovarian hyperstimulation syndrome with ischemic stroke due to an intracardiac thrombus
    G. A. Worrell, E. F.M. Wijdicks, S. D.Z. Eggers et al.
    Neurology, October 09, 2001
Neurology: 100 (12)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise